Differential transgene expression profiles in rat brain, using rAAV2/1 vectors with tetracycline-inducible and cytomegalovirus promoters

Human Gene Therapy

Volumn 19, Issue 11, 2008, Pages 1293-1305

  Bockstael, Olivier ^a   Chtarto, Abdelwahed ^a   Wakkinen, Janica ^a,b   Yang, Xin ^a   Melas, Catherine ^a   Levivier, Marc ^a,c   Brotchi, Jacques ^a   Tenenbaum, Liliane ^a,d  

^a ERASME HOSPITAL   (Belgium)

^b GLYKOS FINLAND LTD   (Finland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d UNIVERSITÉ LIBRE DE BRUXELLES   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVALBUMIN; PARVOVIRUS VECTOR; PHOSPHOPROTEIN DARPP 32; RECOMBINANT ADENOASSOCIATED VIRAL VECTOR PSEUDOTYPED WITH VIRAL CAPSIDS FROM SEROTYPE 1; TETRACYCLINE; TYROSINE 3 MONOOXYGENASE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CYTOMEGALOVIRUS PROMOTER; DOPAMINERGIC NERVE CELL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION SYSTEM; GLOBUS PALLIDUS; INTERNEURON; MESENCEPHALON; NIGRONEOSTRIATAL SYSTEM; NONHUMAN; OLFACTORY BULB; PROMOTER REGION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; SUBSTANTIA NIGRA; SUBSTANTIA NIGRA PARS RETICULATA; SUBVENTRICULAR ZONE; TETRACYCLINE INDUCIBLE EXPRESSION CASSETTE; TRANSGENE; VIRAL GENE DELIVERY SYSTEM;

ANIMALS; BLOTTING, WESTERN; BRAIN; CYTOMEGALOVIRUS; DEPENDOVIRUS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION REGULATION; GENE THERAPY; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; IMMUNOENZYME TECHNIQUES; NEURONS; PROMOTER REGIONS, GENETIC; PROTEIN SYNTHESIS INHIBITORS; RATS; RATS, WISTAR; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SUBSTANTIA NIGRA; TETRACYCLINE; TRANSFECTION; TRANSGENES;

CYTOMEGALOVIRUS; MIRIDAE; RATTUS;

EID: 57049103038     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.2008.099     Document Type: Article

References (44)

1. Alvarez-Buylla, A., and Lim, D. (2004). For the long run maintaining germinal niches in the adult brain. Neuron 41, 683-686.
2. Burger, C., Gorbatyuk, O.S., Velardo, M.J., Peden, C.S., Williams, P., Zolotukhin, S., Reier, P.J., Mandel, R.J., and Muzyczka, N. (2004). Recombinant AAV viral vectors pseudotyped with viral capsids from serotypes 1, 2, and 5 display differential efficiency and cell tropism after delivery to different regions of the central nervous system. Mol. Ther. 10, 302-317.
3. Cearley, C.N., and Wolfe, J.H. (2006). Transduction characteristics of adeno-associated virus vectors expressing cap serotypes 7, 8, 9, and Rh10 in the mouse brain. Mol. Ther. 13, 528-537.
4. Chtarto, A., Yang, X., Bockstael, O., Melas, C., Blum, D., Lehtonen, E., Abeloos, L., Jaspar, J.M., Levivier, M., Brotchi, J., Velu, T., and Tenenbaum, L. (2007). Controlled delivery of glial cell line-derived neurotrophic factor by a tetracycline-inducible AAV vector. Exp. Neurol. 204, 387-399.
5. Davidson, B.L., Stein, C.S., Heth, J.A., Martins, I., Kotin, R.M., Derksen, T.A., Zabner, J., Ghodsi, A., and Chiorini, J.A. (2000). Recombinant adeno-associated virus type 2, 4, and 5 vectors transduction of variant cell types and regions in the mammalian central nervous system. Proc. Natl. Acad. Sci. U.S.A. 97, 3428-3432.
6. Di Pasquale, G., Davidson, B.L., Stein, C.S., Martins, I., Scudiero, D., Monks, A., and Chiorini, J.A. (2003). Identification of PDGFR as a receptor for AAV-5 transduction. Nat. Med. 9, 1306-1312.
7. Donello, J.E., Loeb, J.E., and Hope, T.J. (1998). Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element. J. Virol. 72, 5085-5092.
8. Eslamboli, A., Georgievska, B., Ridley, R.M., Baker, H.F., Muzyczka, N., Burger, C., Mandel, R.J., Annett, L., and Kirik, D. (2005). Continuous low-level glial cell line-derived neurotrophic factor delivery using recombinant adeno-associated viral vectors provides neuroprotection and induces behavioral recovery in a primate model of Parkinson's disease. J. Neurosci. 25, 769-777.
9. Favre, D., Blouin, V., Provost, N., Spisek, R., Porrot, F., Bohl, D., Marmé, F., Chérel, Y., Salvetti, A., Hurtrel, B., Heard, J.M., Rivière, Y., and Moullier, P. (2002). Lack of an immune response against the tetracycline-dependent transactivator correlates with long-term doxycycline-regulated transgene expression in nonhuman primates after intramuscular injection of recombinant adeno-associated virus. J. Virol. 76, 11605-11611.
10. Fitzsimons, H.L., McKenzie, J.M., and During, M.J. (2001). Insulators coupled to a minimal bidirectional tet cassette for tight regulation of rAAV-mediated gene transfer in the mammalian brain. Gene Ther. 8, 1675-1681.
11. Georgievska, B., Kirik, D., and Björklund, A. (2002). Aberrant sprouting and downregulation of tyrosine hydroxylase in lesioned nigrostriatal dopamine neurons induced by long-lasting overexpression of glial cell line derived neurotrophic factor in the striatum by lentiviral gene transfer. Exp. Neurol. 177, 461-474.
12. Gossen, M., and Bujard, H. (1992). Tight control of gene expression in mammalian cells by tetracycline-responsive promoters. Proc. Natl. Acad. Sci. U.S.A. 89, 5547-5551.
13. Gossen, M., Freundlieb, S., Bender, G., Muller, G., Hillen, W., and Bujard, H. (1995). Transcriptional activation by tetracyclines in mammalian cells. Science 268,1766-1769.
14. Graveland, G.A., and DiFiglia, M. (1985). The frequency and distribution of medium-sized neurons with indented nuclei in the primate and rodent neostriatum. Brain Res. 327, 307-311.
15. Haberman, R., Criswell, H., Snowdy, S., Ming, Z., Breese, G., Samulski, R.J., and McCown, T. (2002). Therapeutic liabilities of in vivo viral vector tropism: Adeno-associated virus vectors, NMDAR1 antisense, and focal seizure sensitivity. Mol. Ther. 6 495-500.
16. Hirt, B. (1967). Selective extraction of polyoma DNA from infected mouse cell cultures. J. Mol. Biol. 26, 365-369.
17. Hovland, D.N., Jr., Boyd, R.B., Butt, M.T., Engelhardt, J.A., Moxness, M.S., Ma, M.H., Emery, M.G., Ernst, N.B., Reed, R.P., Zeller, J.R., Gash, D.M., Masterman, D.M., Potter, B.M., Cosenza, M.E., and Lightfoot, R.M. (2007). Six-month continuous intraputamenal infusion toxicity study of recombinant methionyl human glial cell line-derived neurotrophic factor (r-metHuGDNF in rhesus monkeys). Toxicol. Pathol. 35, 1013-1029.
18. Kingsman, S.M., Mitrophanous, K., and Olsen, J.C. (2005). Potential oncogene activity of the woodchuck hepatitis post-transcriptional regulatory element (WPRE). Gene Ther. 12, 3-4.
19. Kirik, D., Rosenblad, C., Björklund, A., and Mandel, R.J. (2000a). Long-term rAAV-mediated gene transfer of GDNF in the rat Parkinson's model: Intrastriatal but not intranigral transduction promotes functional regeneration in the lesioned nigrostriatal system. J. Neurosci. 20, 4686-4700.
20. Kirik, D., Rosenblad, C., and Björklund, A. (2000b). Preservation of a functional nigrostriatal dopamine pathway by GDNF in the intrastriatal 6-OHDA lesion model depends on the site of administration of the trophic factor. Eur. J. Neurosci. 12, 3871-3882.
21. Kirik, D., Rosenblad, C., Burger, C., Lundberg, C., Johansen, T.E., Muzyczka, N., Mandel, R.J., and Björklund, A. (2002). Parkinson-like neurodegeneration induced by targeted overexpression of α-synuclein in the nigrostriatal system. J. Neurosci. 22, 2780-2791.
22. Klein, R.L., Meyer, E.M., Peel, A.L., Zolotukhin, S., Meyers, C., Muzyczka, N., and King, M.A. (1998). Neuron-specific transduction in the rat septohippocampal or nigrostriatal pathway by recombinant adeno-associated virus vectors. Exp. Neurol. 150, 183-194.
23. Klein, R.L., Dayton, R.D., Leidenheimer, N.J., Jansen, K., Golde, T.E., and Zweig, R.M. (2006). Efficient neuronal gene transfer with AAV8 leads to neurotoxic levels of tau or green fluorescent proteins. Mol. Ther. 13, 517-527.
24. Klein, R.L., Dayton, R.D., Tatom, J.B., Henderson, K.M., and Henning, P.P. (2008). AAV8, 9, Rh10, Rh43 vector gene transfer in the rat brain: Effects of serotype, promoter and purification method. Mol. Ther. 16, 89-96.
25. Marks, W.J., Jr., Ostrem, J.L., Verhagen, L., Starr, P.A., Larson, P.S., Bakay, R.A., Taylor, R., Cahn-Weiner, D.A., Stoessl, A.J., Olanow, C.W., and Bartus, R.T. (2008). Safety and tolerability of intraputaminal delivery of CERE-120 (adeno-associated virus serotype 2-neurturin) to patients with idiopathic Parkinson's disease: An open-label, phase I trial. Lancet Neurol. 7, 400-408.
26. McCown, T.J. (2005). Adeno-associated virus (AAV) vectors in the CNS. Curr. Gene Ther. 5, 333-338.
27. Nutt, J.G., Burchiel, K.J., Comella, C.L., Jankovic, J., Lang, A.E., Laws, E.R., Jr., Lozano, A.M., Penn, R.D., Simpson, R.K., Jr., Stacy, M., and Wooten, G.F. (2003). Randomized, double-blind trial of glial cell line-derived neurotrophic factor (GDNF) in PD. Neurology 60, 69-73.
28. Passini, M.A., Watson, D.J., Vite, C.H., Landsburg, D.J., Feigenbaum, A.L., and Wolfe, J.H. (2003). Intraventricular brain injection of adeno-associated virus type 1 (AAV1) in neonatal mice results in complementary patterns of neuronal transduction to AAV2 and total long-term correction of storage lesions in the brains of β-glucuronidase-deficient mice. J. Virol. 77, 7034-7040.
29. Paterna, J.C., Moccetti, T., Mura, A., Feldon, J., and Bueler, H. (2000). Influence of promoter and WHV post-transcriptional regulatory element on AAV-mediated transgene expression in the rat brain. Gene Ther. 7, 1304-1311.
30. Paterna, J.C., Feldon, J., and Bueler, H. (2004). Transduction profiles of recombinant adeno-associated virus vectors derived from serotypes 2 and 5 in the nigrostriatal system of rats. J. Virol. 78 , 6808-6817.
31. Paxinos, G., and Watson, C. (1997). The rat brain in stereotaxic coordinates, 3rd compact edition (Academic Press, Orlando, FL).
32. Peterson, A.L., and Nutt, J.G. (2008). Treatment of Parkinson's disease with trophic factors. Neurotherapeutics 5, 270-280.
33. Qing, K., Mah, C., Hansen, J., Zhou, S., Dwarki, V., and Srivastava, A. (1999). Human fibroblast growth factor receptor 1 is a co-receptor for infection by adeno-associated virus 2. Nat. Med. 5, 71-77.
34. Rabinowitz, J.E., Rolling, F., Li, C., Conrath, H., Xiao, W., Xiao, X., and Samulski, R.J. (2002). Cross-packaging of a single adeno-associated virus (AAV) type 2 vector genome into multiple AAV serotypes enables transduction with broad specificity. J. Virol. 76, 791-801.
35. Salvetti, A., Oreve, S., Chadeuf, G., Favre, D., Cherel, Y., Champion-Arnaud, P., David-Ameline, J., and Moullier, P. (1999). Factors influencing recombinant adeno-associated virus production. Hum. Gene Ther. 9, 695-706.
36. Sterio, D.C. (1984). The unbiased estimation of number and sizes of arbitrary particles using the disector. J. Microsc. 134, 127-136.
37. Summerford, C., and Samulski, R.J. (1998). Membrane-associated heparan sulfate proteoglycan is a receptor for adeno-associated virus type 2 virions. J. Virol. 72, 1438-1445.
38. 5 Integrin a co-receptor for adeno-associated virus type 2 infection. Nat. Med. 5, 78-82.
39. Taymans, J.M., Vandenberghe, L.H., Haute, C.V., Thiry, I., Deroose, C.M., Mortelmans, L., Wilson, J.M., Debyser, Z., and Baekelandt, V. (2007). Comparative analysis of adeno-associated viral vector serotypes 1, 2, 5, 7, and 8 in mouse brain. Hum. Gene Ther. 18, 195-206.
40. Tenenbaum, L., Jurysta, F., Stathopoulos, A., Puschban, Z., Melas, C., Hermens, W.T., Verhaagen, J., Pichon, B., Velu, T., and Levivier, M. (2000).Tropism of AAV-2 vectors for neurons of the globus pallidus. Neuroreport 11, 2277-2283.
41. Walters, R.W., Yi, S.M., Keshavjee, S., Brown, K.E., Welsh, M.J., Chiorini, J.A., and Zabner, J. (2001). Binding of adeno-associated virus type 5 to 2,3-linked sialic acid is required for gene transfer. J. Biol. Chem. 276, 20610-20616.
42. Wang, C., Wang, C.M., Clark, K.R., and Sferra, T.J. (2003). Recombinant AAV serotype 1 transduction efficiency and tropism in the murine brain. Gene Ther. 10, 1528-1534.
43. Wu, Z., Miller, E., Agbandje-McKenna, M., and Samulski, R.J. (2006). α2,3 and α2,6 N-linked sialic acids facilitate efficient binding and transduction by adeno-associated virus types 1 and 6. J. Virol. 80, 9093-9103.
44. Xiong, W., Candolfi, M., Kroeger, K.M., Puntel, M., Mondkar, S., Larocque, D., Liu, C., Curtin, J.F., Palmer, D., Ng, P., Lowenstein, P.R., and Castro, M.G. (2008). Immunization against the transgene but not the TetON switch reduces expression from gutless adenoviral vectors in the brain. Mol. Ther. 16, 343-351.